DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Ettl J, Quek RGW, Lee KH. et al
Quality of life with talazoparib versus physicianʼs choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
Ann Oncol 2018;
29: 1939-1947
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.